Literature DB >> 16177161

Outcomes of fundoplication: causes for concern, newer options.

E Hassall1.   

Abstract

Antireflux surgery has been a mainstay of treatment for gastro-oesophageal reflux disease in children for some 40 years. In recent years, enthusiasm for antireflux surgery seems only to have increased, despite its often poor outcome, and the availability of highly effective medical therapy in the form of proton pump inhibitors (PPIs). Reports show that many children undergo surgery without reflux disease as the demonstrable cause of their symptoms/signs, and without evidence of having failed optimised medical management. Very few studies report objective testing postoperatively--those that do show high rates of failure within the first 1-3 years following surgery. Treatment with PPIs is an effective and safe alternative to surgery in many cases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177161      PMCID: PMC1720136          DOI: 10.1136/adc.2004.069674

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  66 in total

Review 1.  Co-morbidities in childhood Barrett's esophagus.

Authors:  E Hassall
Journal:  J Pediatr Gastroenterol Nutr       Date:  1997-09       Impact factor: 2.839

2.  Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition.

Authors:  C D Rudolph; L J Mazur; G S Liptak; R D Baker; J T Boyle; R B Colletti; W T Gerson; S L Werlin
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001       Impact factor: 2.839

3.  The failure rate of surgery for gastro-oesophageal reflux.

Authors:  C Kimber; E M Kiely; L Spitz
Journal:  J Pediatr Surg       Date:  1998-01       Impact factor: 2.545

4.  Failure of the Nissen fundoplication to control gastroesophageal reflux in esophageal atresia patients.

Authors:  H Lindahl; R Rintala; I Louhimo
Journal:  J Pediatr Surg       Date:  1989-10       Impact factor: 2.545

Review 5.  Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children.

Authors:  Eric Hassall
Journal:  J Pediatr       Date:  2005-03       Impact factor: 4.406

6.  Chronic lung disease is the leading risk factor correlating with the failure (wrap disruption) of antireflux procedures in children.

Authors:  L A Taylor; T Weiner; S R Lacey; R G Azizkhan
Journal:  J Pediatr Surg       Date:  1994-02       Impact factor: 2.545

7.  Gastroesophageal reflux: prevalence in adults older than 28 years after correction of esophageal atresia.

Authors:  Jacqueline A Deurloo; Seine Ekkelkamp; Joep F W M Bartelsman; Fibo J W Ten Kate; Mak Schoorl; Hugo A Heij; Daniel C Aronson
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

8.  Recognition of recurrent gastroesophageal reflux following antireflux surgery in the neurologically disabled child: high index of suspicion and definitive evaluation.

Authors:  D A Martinez; M E Ginn-Pease; D A Caniano
Journal:  J Pediatr Surg       Date:  1992-08       Impact factor: 2.545

Review 9.  Barrett's esophagus: new definitions and approaches in children.

Authors:  E Hassall
Journal:  J Pediatr Gastroenterol Nutr       Date:  1993-05       Impact factor: 2.839

10.  Long-term follow-up of surgery for gastroesophageal reflux in infants and children.

Authors:  J K Harnsberger; J J Corey; D G Johnson; J J Herbst
Journal:  J Pediatr       Date:  1983-04       Impact factor: 4.406

View more
  17 in total

1.  Long-term outcome of laparoscopic Nissen-Rossetti fundoplication for neurologically impaired and normal children.

Authors:  C Capito; M-D Leclair; H Piloquet; V Plattner; Y Heloury; G Podevin
Journal:  Surg Endosc       Date:  2007-10-26       Impact factor: 4.584

Review 2.  New insights in gastroesophageal reflux, esophageal function and gastric emptying in relation to dysphagia before and after anti-reflux surgery in children.

Authors:  M J Smits; C M Loots; M A Benninga; T I Omari; M P van Wijk
Journal:  Curr Gastroenterol Rep       Date:  2013-10

Review 3.  Gastroesophageal reflux disease in children and adolescents: when and how to treat.

Authors:  Matthew W Carroll; Kevan Jacobson
Journal:  Paediatr Drugs       Date:  2012-04-01       Impact factor: 3.022

Review 4.  Outcomes of pediatric laparoscopic fundoplication: a critical review of the literature.

Authors:  Kathryn Martin; Catherine Deshaies; Sherif Emil
Journal:  Can J Gastroenterol Hepatol       Date:  2013-11-28

Review 5.  Current pharmacological management of gastro-esophageal reflux in children: an evidence-based systematic review.

Authors:  Mark P Tighe; Nadeem A Afzal; Amanda Bevan; R Mark Beattie
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

6.  Evaluation of antireflux surgery using multichannel intraluminal impedance-pH measurement in neurologically impaired patients.

Authors:  Aya Tanaka; Ryuichi Shimono; Hiroyuki Kubo; Takayuki Fujii; Nobuyuki Miyatake
Journal:  Pediatr Surg Int       Date:  2015-08-19       Impact factor: 1.827

Review 7.  Step-up and step-down approaches to treatment of gastroesophageal reflux disease in children.

Authors:  Eric Hassall
Journal:  Curr Gastroenterol Rep       Date:  2008-06

Review 8.  Is there a changing trend in surgical management of gastroesophageal reflux disease in children?

Authors:  Mahmud Saedon; Stavros Gourgiotis; Stylianos Germanos
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

9.  Effects of rikkunshito on the clinical symptoms and esophageal acid exposure in children with symptomatic gastroesophageal reflux.

Authors:  Hisayoshi Kawahara; Akio Kubota; Toshimichi Hasegawa; Hiroomi Okuyama; Takehisa Ueno; Shinobu Ida; Masahiro Fukuzawa
Journal:  Pediatr Surg Int       Date:  2007-10       Impact factor: 1.827

10.  Prevalence of pediatric aspiration-associated extraesophageal reflux disease.

Authors:  Elizabeth A Kelly; Daiva E Parakininkas; Steven L Werlin; James F Southern; Nikki Johnston; Joseph E Kerschner
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2013-10       Impact factor: 6.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.